NeuMoDx Molecular, Ann Arbor, Mich, has released new software for its NeuMoDx 288 and 96 molecular systems that introduces ‘extraction-only’ capabilities, among other enhancements. The extraction-only feature provides users the option for a faster extraction process to enhance their molecular testing.

The NeuMoDx 288 and 96 molecular systems are capable of extracting DNA and RNA from approximately 400 and 200 samples in an 8-hour period, respectively. By introducing a high-performance extractor on top of the abilities of a sample-to-result solution, the NeuMoDx molecular systems offer flexibility to consolidate platforms.

Sundu Brahmasandra, PhD, NeuMoDx Molecular.

Sundu Brahmasandra, PhD, NeuMoDx Molecular.

“With the NeuMoDx molecular solutions, our customers have had access to sophisticated, seamless workflows enabling continuous loading, true random access, and rapid turnaround times for sample-to-result in vitro diagnostics/laboratory-developed test implementations,” says Sundu Brahmasandra, PhD, NeuMoDx president and chief operating officer. “By extending these capabilities to include extraction-only operation, our users can now harness the benefit of a high-throughput and universal nucleic acid extraction system that is able to simultaneously process a wide variety of clinical specimen matrices for high-quality DNA/RNA extractions.”

For more information, visit NeuMoDx Molecular.